Publicité
Publicité

DTIL

DTIL logo

Precision BioSciences, Inc. Common Stock

3.92
USD
Sponsorisé
-0.11
-2.73%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

3.95

+0.03
+0.77%

DTIL Rapports sur les bénéfices

Ratio de surprise positive

DTIL a dépassé 15 des 27 dernières estimations.

56%

Prochain rapport

Date du prochain rapport
24 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.26M
/
-$0.54
Variation implicite de Q3 25 (Revenue/ EPS)
+71103.85%
/
-70.65%
Variation implicite de Q4 24 (Revenue/ EPS)
+1350.86%
/
-75.68%

Precision BioSciences, Inc. Common Stock earnings per share and revenue

On 03 nov. 2025, DTIL reported earnings of -1.84 USD per share (EPS) for Q3 25, missing the estimate of -1.36 USD, resulting in a -34.62% surprise. Revenue reached 13.00 mille, compared to an expected 5.51 million, with a -99.76% difference. The market reacted with a -9.80% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analystes forecast an EPS of -0.54 USD, with revenue projected to reach 9.26 million USD, implying an baisse of -70.65% EPS, and hausse of 71103.85% in Revenue from the last quarter.
FAQ
For Q3 2025, Precision BioSciences, Inc. Common Stock reported EPS of -$1.84, missing estimates by -34.62%, and revenue of $13.00K, -99.76% below expectations.
The stock price moved down -9.8%, changed from $8.16 before the earnings release to $7.36 the day after.
The next earning report is scheduled for 24 mars 2026.
Based on 6 analystes, Precision BioSciences, Inc. Common Stock is expected to report EPS of -$0.54 and revenue of $9.26M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité